Exercise may protect muscle during obesity drug weight loss

NCT ID NCT07698145

First seen Jul 13, 2026 · Last updated Jul 16, 2026 · Updated 3 times

Summary

This study investigates whether adding cardiovascular or resistance exercise to standard obesity medication helps adults with overweight or obesity retain lean muscle mass while losing weight. Participants are prescribed an FDA-approved obesity medication by their doctor and are randomly assigned to also receive supervised exercise training or medication alone. The trial measures changes in muscle mass, body composition, fitness, and strength over six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Obesity management medication (e.g., tirzepatide, semaglutide) plus exercise
What this could lead to
If exercise helps retain muscle during weight loss, this could point toward better long-term health outcomes for people taking obesity medications.
What could go wrong
This is a relatively small, early-stage study. Results may not apply to all medications or populations, and exercise adherence can be challenging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Motor Activity Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Kansas Medical Center

    RECRUITING

    Kansas City, Kansas, 66160, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.